Annual Clinical Research Day event highlights RI-MUHC services and expertise in clinical trials
The Centre for Innovative Medicine and many other clinical research support teams introduced their skills...
Two RI-MUHC researchers receive funding from the Marathon of Hope Cancer Centres Network
Morag Park, Ph.D. and George Zogopoulos, MD., Ph.D., are two of the four beneficiaries of the Pan-Canadian...
Lucy Gilbert honoured for publication in Gynecologic Oncology
The most cited publication and one of the journal’s most read in 2023
Earth Day 2024 at the RI-MUHC: Towards greater sustainability
Organization-wide teamwork is reducing the environmental footprint of research
New findings illustrate pathway for screening high-risk individuals for pancreatic cancer
An international collaboration of scientists and healthcare professionals is developing a promising surveillance...
A new hope for men with metastatic prostate cancer
MUHC patients are the first enrolled in a new global Phase 1 clinical trial testing Actinium-225, a therapeutic agent used in nuclear precision medicine
An opportunity to learn, celebrate and connect during Black History Month at the RI-MUHC
An expert panel explored Equity, Diversity and Inclusion in research and healthcare
Outstanding early-career researcher at the RI-MUHC named Terry Fox New Investigator
Joanna Przybyl receives one of seven 2024 Terry Fox New Investigator awards for her work in osteosarcoma
Results of seed funding competition in precision oncology
The RI-MUHC’s Cancer Research Program is pleased to announce the winners of Precision Oncology Hypothesis-Driven Seed Funding Competition
$3 million for FRQS Dual Chairs in Artificial Intelligence and Health co-led by RI-MUHC researchers
The FRQS Dual AI Chairs Program supports research collaborations across disciplines in pursuit of the significant...